Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
530.00    0.00 (0.00%)
Bid:
0.00
Ask:
535.00
Spread: 5.00 (0.943%)
Market Cap: £305.35m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Directorate changes

11 Dec 2025 07:00

RNS Number : 0703L
Mortgage Advice Bureau (Hldgs) PLC
11 December 2025
 

11 December 2025

Mortgage Advice Bureau (Holdings) plc

("MAB" or the "Group")

 

Directorate Changes

 

Mortgage Advice Bureau (Holdings) plc (AIM: MAB1.L), a leading technology-driven UK mortgage network and broker, announces the following changes to the Board:

 

Appointment of Chief Operating Officer (COO) to the Board

MAB has appointed Yaiza Patricia Luengo Morales (Yaiza Luengo), COO, to the Board with effect from 1 January 2026, subject to regulatory approvals.

 

Yaiza joined MAB as COO and member of the Executive Committee on 8 September 2025. She brings over 20 years' international experience in financial services, with a strong track record in large-scale transformation, revenue leadership and operational restructuring in regulated environments. She has led technology-enabled change across cloud and data architecture, Artificial Intelligence (AI), digital customer experience and enterprise platforms. Her previous senior executive roles include positions at RBS, Barclays, HSBC, Refinitiv (now part of LSEG), and WiZink Bank.

 

Deputy Chief Executive Officer (Deputy CEO) to step down from the Board

Ben Thompson will step down as Deputy CEO and as a director of MAB with effect from 31 December 2025. As previously announced, Ben will transition into a newly created strategic role focused on building new value by optimising MAB's mortgage opportunity and broadening and strengthening its customer proposition.

 

Mike Jones, Non-Executive Chair, said:

"Yaiza has already made a positive impact since joining MAB as Chief Operating Officer. Her considerable operational experience and technology background will provide important leadership as we deliver on our medium-term growth targets, and we are pleased to welcome her to the Board.

 

Since joining the Group in 2018, Ben has been a key member of the team that has delivered significant revenue and market share growth at MAB. I am delighted that his major contribution to the business will continue in his new strategic role."

 

Regulatory disclosures

The following information is provided in accordance with AIM Rule 17 and Schedule Two (g) of the AIM Rules for Companies:

Yaiza Luengo, aged 44 years, currently holds or has held the following directorships and partnerships in the last five years:

Current Directorships/Partnerships

Casalogica Ltd - Director

 

People Risk Management Limited - Director

 

Big Wave Studios AI Ltd - Director

 

Clinsj AS (a Norwegian company) - Director

 

Yaiza Luengo holds options over 77,509 shares in MAB, subject to the relevant plan rules.

 

MAB is not aware of any further disclosures required under these provisions with respect to the appointment of Yaiza Luengo.

 

 

Enquiries:

Mortgage Advice Bureau (Holdings) plc

Via Camarco

 

Peter Brodnicki, Chief Executive Officer

Emilie McCarthy, Chief Financial Officer 

Nominated Adviser and Joint Broker

Keefe, Bruyette & Woods, a Stifel Company

Erik Anderson / Jason Grossman / Francis North

 

 

+44 (0) 20 7710 7600

Joint Broker

Berenberg

James Felix / Michael Burke / Dan Gee-Summons 

 

 

+44 (0) 20 3207 7800

Joint Broker

Peel Hunt LLP

Andrew Buchanan / Thomas Philpot / Rob Parker

 

+44 (0) 20 7418 8900

Media Enquiries

Camarco

Tom Huddart / Letaba Rimell

 

 

mab@camarco.co.uk

Investor Relations

 

Investor.relations@mab.org.uk

 

About MAB:

MAB is one of the UK's leading consumer intermediary brands and specialist networks for mortgage advisers. 

Through its partner firms known as Appointed Representatives (ARs), MAB has over 2,000 advisers providing expert advice to customers on a range of mortgage, specialist lending, protection, and general insurance products. MAB supports its AR firms with proprietary technology and services, including adviser recruitment and lead generation, learning and development, compliance auditing and supervision, and digital marketing and website solutions.

For more information, visit www.mortgageadvicebureau.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAKAEFEKSFFA
Date   Source Headline
23rd Dec 20254:25 pmRNSIssuance of Shares and Total Voting Rights
17th Dec 202512:01 pmRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSDirectorate changes
4th Dec 20259:25 amRNSStandard form for notification of major holdings
1st Dec 20255:25 pmRNSDirectors' Shareholdings and PDMR notification
18th Nov 20252:11 pmRNSDirectors' Shareholdings and PDMR notification
14th Nov 20257:00 amRNSNotice of Capital Markets Day Update
7th Nov 20255:15 pmRNSHolding(s) in Company
4th Nov 20251:34 pmRNSDirector/PDMR Shareholding
16th Oct 202512:40 pmRNSDirector/PDMR Shareholding
16th Oct 202512:38 pmRNSGrant of Options, PDMR Dealing,Total Voting Rights
30th Sep 20254:43 pmRNSDirector/PDMR Shareholding
25th Sep 20254:30 pmRNSDirector/PDMR Shareholding
23rd Sep 20255:01 pmRNSBlock listing Interim Review
23rd Sep 20257:00 amRNSInterim Results
17th Sep 20252:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20257:00 amRNS-RNotice of HY25 Results and Investor Presentation
29th Aug 20251:13 pmRNSDirector/PDMR Shareholding
27th Aug 20254:26 pmRNSHolding(s) in Company
21st Aug 20253:01 pmRNSDirector/PDMR Shareholding
31st Jul 202511:32 amRNSDirector/PDMR Shareholding
24th Jul 20257:00 amRNSTrading Update
22nd Jul 20255:59 pmRNSEBT Share Purchase
17th Jul 20259:46 amRNSDirector/PDMR Shareholding
16th Jul 20251:58 pmRNSHolding(s) in Company
9th Jul 20259:05 amRNS-RMAB Launches First-Time Buyer Campaign
3rd Jul 20259:54 amRNSDirector/PDMR Shareholding
27th Jun 20253:46 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSBoard Changes
18th Jun 202510:55 amRNSDirector/PDMR Shareholding
11th Jun 202510:18 amRNSHolding(s) in Company
3rd Jun 20252:47 pmRNSDirector/PDMR Shareholding
30th May 20253:52 pmRNSDirector/PDMR Shareholding
22nd May 20257:00 amRNSResults of Annual General Meeting
21st May 20257:00 amRNSAGM Trading Statement
16th May 202512:30 pmRNSDirector/PDMR Shareholding
6th May 202512:37 pmRNSHolding(s) in Company
1st May 20255:19 pmRNSDirectors' Shareholdings and PDMR notification
30th Apr 20255:15 pmRNSGrant of Options, PDMR Dealing and TVR
29th Apr 20258:48 amRNSNotice of AGM
17th Apr 20251:40 pmRNSHolding(s) in Company
16th Apr 20259:58 amRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSAppointment of Joint Corporate Broker
4th Apr 20257:10 amRNSAnnual Report and Notice of AGM
1st Apr 20253:51 pmRNSDirector/PDMR Shareholding
27th Mar 20259:18 amRNSHolding(s) in Company
19th Mar 20257:00 amRNSDirectorate Change
18th Mar 20257:00 amRNSFinal Results for the year ended 31 December 2024
17th Mar 20253:40 pmRNSDirector/PDMR Shareholding
14th Mar 20257:00 amRNSBlock Admission Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.